Researchers Use Hybrid Quantum-Classical Workflow to Identify KRAS Inhibitors

figure chart

A multi-institution team of researchers led by Mohammad Ghazi Vakili (University of Toronto) and Christoph Gorgulla (St. Jude Children’s Research Hospital and Harvard University) reported using a hyrbid quantum-classical workflow to identify KRAS inhibitor drug candidates. KRAS is a well-known cancer causing gene.

The post Researchers Use Hybrid Quantum-Classical Workflow to Identify KRAS Inhibitors appeared first on HPCwire.

More Related Posts

The Leading Robotics and Automation Stories, Trends and Milestones of 2021

In this Robot Report podcast, WTWH Media’s Robotics Group review the leading...

Ironhand soft robotic glove uses FAULHABER drives to help reduce worker strain

The 1741 … CXR motor. Source: FAULHABER Musculoskeletal disorders are a common...

ORNL Researchers Reach Quantum Networking Milestone in Real-World Environment

A team from the U.S. Department of Energy’s Oak Ridge National Laboratory,...

Home

Highly Niched Headhunters Specialized in Physical AI/Robotics, High-Performance Computing, Unmanned/Autonomous Systems, Defense Technology and Energy.

Specializations

We recruit across complex engineering markets where understanding the technology is critical to finding the right talent.

How We Work

Overview of how PACE partners with teams: Our process, what clients get, and why PACE is different.

About Us

PACE’s story, values, and culture define how we operate and who we are.

News & Insights

Stay up to date on industry trends.

Contact

All the information needed for anyone interested in contacting us.